Moody's: Global drugmakers to bounce back this year

04/26/2013 | PharmaTimes (U.K.)

The global pharmaceutical market is poised to return to earnings growth this year as the patent cliff eases, according to a report from Moody's. Merger and acquisition deals will likely increase, but transactions will be in the small to midsize range. In the U.S., the regulatory pathway for biosimilars will get clearer, with potential regulatory applications this year, according to the report.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ